Eli Lilly's Tirzepatide Outshines Novo Nordisk's Semaglutide, Yet Brand Recognition Remains Strong for Novo's Products ...
Major indexes were down slightly in afternoon trading Wednesday as the stock market struggled to recover from the previous session's steep losses.
Hosted on MSN1h
UBS Upgrades Advanced Drainage Systems (WMS)Fintel reports that on January 8, 2025, UBS upgraded their outlook for Advanced Drainage Systems (NYSE:WMS) from Neutral to ...
Hosted on MSN1h
UBS Downgrades JELD-WEN Holding (JELD)Fintel reports that on January 8, 2025, UBS downgraded their outlook for JELD-WEN Holding (NYSE:JELD) from Buy to Neutral.
We recently compiled a list of the 9 Stocks Poised for Gains as AI Reaches New Heights in 2025. In this article, we are going ...
We recently compiled a list of the 9 Stocks Poised for Gains as AI Reaches New Heights in 2025. In this article, we are going ...
Novo Nordisk's U.S.-listed and domestic shares rose Wednesday after analysts from UBS upgraded the Danish drugmaker's stock ...
UBS ETRACS Crude Oil Shares offers conservative long-oil exposure through covered-call strategy & bullish seasonality, ideal ...
UBS Securities on Wednesday upgraded PulteGroup (NYSE:PHM) stock to Buy from Neutral, highlighting promising margins, while ...
Tesla Inc. could collect more than €1 billion ($1 billion) in compensation from rival automakers that need help meeting ...
Investing.com -- Nvidia (NASDAQ: NVDA ), Microsoft (NASDAQ: MSFT ), and OpenAI are the key AI beneficiaries, UBS analysts said, citing results of its latest enterprise AI survey. The survey, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback